Knight Therapeutics Inc. (GUD.TO)
CAD 5.21
(-0.19%)
CAD 5.21
(-0.19%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 328.19 Million | 293.56 Million | 243.47 Million | 199.51 Million | 47.46 Million | 12.5 Million |
| Cost of Revenue | 175.54 Million | 155.5 Million | 128.06 Million | 117.82 Million | 20.54 Million | 2.3 Million |
| Gross Profit | 152.65 Million | 138.06 Million | 115.41 Million | 81.69 Million | 26.91 Million | 10.19 Million |
| Operating Expenses | 155.54 Million | 155.12 Million | 128.24 Million | 111.69 Million | 39.57 Million | 15.97 Million |
| Selling, General and Administrative Expenses | 83.69 Million | 88.62 Million | 74.37 Million | 74.43 Million | 32.24 Million | 12.05 Million |
| Research and Development Expenses | 17.54 Million | 14.75 Million | 12.69 Million | 11.72 Million | 3.91 Million | 1.99 Million |
| Other Expenses | 54.3 Million | 51.74 Million | 41.17 Million | 25.53 Million | 3.41 Million | 1.97 Million |
| Cost and Expenses | 331.08 Million | 310.62 Million | 256.31 Million | 229.51 Million | 60.11 Million | 18.28 Million |
| Operating Income | -2.89 Million | -2.4 Million | -5.32 Million | -3.43 Million | 13.98 Million | -5.78 Million |
| Interest Expense | 12.48 Million | 6.6 Million | 3.61 Million | 3.39 Million | 1.01 Million | 20.93 Million |
| Income Tax Expense | -5.15 Million | -14.06 Million | -8.98 Million | 325 Thousand | 4.74 Million | 5.38 Million |
| Earnings before Tax | -21.98 Million | -43.96 Million | 6.69 Million | 32.08 Million | 22.78 Million | 29.46 Million |
| Net Income | -16.83 Million | -29.89 Million | 15.67 Million | 31.76 Million | 14.51 Million | 24.07 Million |
| Earnings Per Share Basic | -0.16 | -0.26 | 0.13 | 0.24 | 0.10 | 0.17 |
| Earnings Per Share Diluted | -0.16 | -0.26 | 0.13 | 0.24 | 0.10 | 0.17 |
| Weighted Average Shares Outstanding | 107.46 Million | 114.89 Million | 124.48 Million | 131.78 Million | 139.75 Million | 142.82 Million |
| Weighted Average Shares Outstanding (Diluted) | 107.46 Million | 114.89 Million | 124.52 Million | 131.98 Million | 140.13 Million | 143.27 Million |
| Gross Margin | 0.47 | 0.47 | 0.47 | 0.41 | 0.57 | 0.82 |
| EBIT Margin | 0.12 | 0.21 | 0.17 | 0.14 | 0.38 | -1.25 |
| Profit Margin | -0.05 | -0.10 | 0.06 | 0.16 | 0.31 | 1.93 |
| EBITDA | 40.89 Million | 25.26 Million | 42.59 Million | 67.55 Million | 27.16 Million | -3.85 Million |
| Earnings Before Tax Margin | -0.01 | -0.01 | -0.02 | -0.02 | 0.29 | -0.46 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 95.57 Million | 86.6 Million | 328.19 Million | 74.19 Million | 81.5 Million | 89.9 Million |
| Cost of Revenue | 59.91 Million | 55.77 Million | 220.58 Million | 51.09 Million | 41.31 Million | 52.41 Million |
| Gross Profit | 35.66 Million | 30.82 Million | 107.61 Million | 23.1 Million | 40.18 Million | 37.49 Million |
| Operating Expenses | 31.16 Million | 28.16 Million | 101.18 Million | 23.12 Million | 39.25 Million | 37.6 Million |
| Selling, General and Administrative Expenses | 25.36 Million | 23.18 Million | - | 18.86 Million | 23 Million | 21.99 Million |
| Research and Development Expenses | 5.8 Million | 4.98 Million | - | 4.25 Million | 4.76 Million | 4.33 Million |
| Other Expenses | 42 Thousand | 169 Thousand | 2.9 Million | 782 Thousand | 1.9 Million | 310 Thousand |
| Cost and Expenses | 91.07 Million | 83.94 Million | 321.77 Million | 74.22 Million | 80.57 Million | 90.01 Million |
| Operating Income | 4.49 Million | 2.66 Million | 6.42 Million | -27 Thousand | 930 Thousand | -110 Thousand |
| Interest Expense | 2.28 Million | 2.57 Million | 12.48 Million | 4.09 Million | 2.6 Million | 3 Million |
| Income Tax Expense | 2.65 Million | -2.59 Million | -5.15 Million | -1.82 Million | -690 Thousand | -1.62 Million |
| Earnings before Tax | 713 Thousand | -7.14 Million | -21.98 Million | -26.15 Million | 8.89 Million | 212 Thousand |
| Net Income | -1.94 Million | -4.54 Million | -16.83 Million | -24.32 Million | 9.58 Million | 1.84 Million |
| Earnings Per Share Basic | -0.02 | -0.04 | - | -0.24 | 0.09 | 0.02 |
| Earnings Per Share Diluted | -0.02 | -0.04 | - | -0.24 | 0.09 | 0.02 |
| Weighted Average Shares Outstanding | 101.33 Million | 101.17 Million | 107.46 Million | 101.17 Million | 106.25 Million | 108.47 Million |
| Weighted Average Shares Outstanding (Diluted) | 101.33 Million | 101.17 Million | 107.46 Million | 101.17 Million | 106.51 Million | 108.67 Million |
| Gross Margin | 0.37 | 0.36 | 0.33 | 0.31 | 0.49 | 0.42 |
| EBIT Margin | 0.18 | 0.18 | - | 0.15 | 0.24 | 0.17 |
| Profit Margin | -0.02 | -0.05 | -0.05 | -0.33 | 0.12 | 0.02 |
| EBITDA | 17.66 Million | 15.24 Million | - | 11.43 Million | 19.59 Million | 15.44 Million |
| Earnings Before Tax Margin | 0.05 | 0.03 | 0.02 | -0.00 | 0.01 | -0.00 |
SWIN
HFBK
000833
YEWTF
001213
NTOIY